Nuclear_JJ
factor-kappaB_NN
activation_NN
in_IN
human_JJ
monocytes_NNS
stimulated_VBN
with_IN
lipopolysaccharide_NN
is_VBZ
inhibited_VBN
by_IN
fibroblast_NN
conditioned_JJ
medium_NN
and_CC
exogenous_JJ
PGE2_NN
._.

The_DT
nuclear_JJ
factor_NN
kappaB_NN
-LRB-_-LRB-
NF-kappaB_NN
-RRB-_-RRB-
is_VBZ
thought_VBN
to_TO
be_VB
crucially_RB
involved_VBN
in_IN
the_DT
gene_NN
activation_NN
of_IN
several_JJ
cytokines_NNS
,_,
including_VBG
tumor_NN
necrosis_NN
factor_NN
alpha_NN
-LRB-_-LRB-
TNF_NN
-RRB-_-RRB-
._.

Previously_RB
,_,
we_PRP
showed_VBD
that_IN
fibroblast_NN
conditioned_JJ
medium_NN
-LRB-_-LRB-
FCM_NN
-RRB-_-RRB-
is_VBZ
able_JJ
to_TO
inhibit_VB
both_CC
TNF_NN
mRNA_NN
accumulation_NN
and_CC
protein_NN
release_NN
in_IN
peripheral_JJ
blood-derived_JJ
human_JJ
monocytes_NNS
-LRB-_-LRB-
PBM_NNS
-RRB-_-RRB-
stimulated_VBN
with_IN
lipopolysaccharide_NN
-LRB-_-LRB-
LPS_NN
-RRB-_-RRB-
._.

In_IN
this_DT
study_NN
we_PRP
have_VBP
investigated_VBN
the_DT
effect_NN
of_IN
FCM_NN
on_IN
the_DT
LPS-induced_JJ
DNA-binding_JJ
activity_NN
of_IN
NF-kappaB_NN
,_,
by_IN
means_NNS
of_IN
electrophoretic_JJ
shift_NN
assay_NN
-LRB-_-LRB-
EMSA_NN
-RRB-_-RRB-
._.

We_PRP
provide_VBP
evidence_NN
that_IN
FCM_NN
strongly_RB
inhibits_VBZ
the_DT
LPS-induced_JJ
NF-kappaB_NN
activation_NN
in_IN
PBM_NNS
._.

Furthermore_RB
,_,
we_PRP
show_VBP
that_IN
exogenous_JJ
PGE2_NN
mimics_VBZ
the_DT
NF-kappaB_NN
inhibitory_JJ
effect_NN
of_IN
FCM_NN
._.

On_IN
the_DT
other_JJ
hand_NN
,_,
FCM_NN
produced_VBN
in_IN
the_DT
presence_NN
of_IN
indomethacin_NN
does_VBZ
not_RB
inhibit_VB
NF-kappaB_NN
activation_NN
by_IN
LPS_NN
._.

Our_PRP$
results_NNS
lend_VBP
further_RB
support_NN
to_TO
the_DT
hypothesis_NN
that_IN
inflammatory_JJ
and_CC
immune_JJ
responses_NNS
of_IN
monocytes\/macrophages_NNS
may_MD
be_VB
modulated_VBN
at_IN
the_DT
molecular_JJ
level_NN
by_IN
signals_NNS
originating_VBG
from_IN
tissue_NN
structural_JJ
cells_NNS
such_JJ
as_IN
fibroblasts_NNS
._.

